# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Srinivasa Ramanujan (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET020-SYN-TD
- Date: 1917-01-14
- Fictional facility: St. Posthumous Health Center
- Fictional author: Edmund Ashworth, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Results of the abdominal ultrasound, serology and tuberculosis tests, with an infectious diseases consultation, and start of treatment. **S**

## History of present illness

Mr. Ramanujan returns two days after his first visit. He had the abdominal ultrasound yesterday morning and gave the second and third induced sputum samples yesterday and this morning, staying in his room in between as asked. He still has evening fevers, last night to 38.4 °C, with sweats, and the dull ache under his right ribs, worse when he breathes in deeply. He is eating little and taking acetaminophen. He has had no diarrhea for several years. He has read about tuberculosis and is frightened of it. He met Dr. Raghunathan of infectious diseases here today. **S**

| Element | Detail |
|---|---|
| Fever | Evening fevers to 38.4 °C with sweats |
| Pain | Dull right upper quadrant ache, worse on deep breathing |
| Tests since intake | Ultrasound yesterday; sputum samples two and three |
| Concern | Afraid he has tuberculosis |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Evening fevers, sweats, tiredness, poor appetite |
| Respiratory | Positive | Pain at the right base on deep breathing; slight dry cough; no blood in the sputum |
| Gastrointestinal | Positive | Right upper quadrant ache; no diarrhea, blood in the stool or jaundice |
| Neurological | Negative | No numbness or tingling |
| Psychiatric | Positive | Worried and low; no thoughts of self-harm |

5 systems reviewed. **S**

## Current medications

- Metronidazole 250 mg oral tablet, three tablets (750 mg) three times a day with food for 10 days **S**
- Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet daily **S**
- Cholecalciferol 50,000 unit (1.25 mg) oral tablet, one tablet once a week for 8 weeks **S**

## Allergies

- No known allergy **S**

## Objective

BP 110/68 mmHg; pulse 100 bpm; respirations 18/min; temperature 38.2 °C; oxygen saturation 97% on room air; weight 51.8 kg; BMI 19 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Thin and tired; temperature 38.2 °C, pulse 100; weight 51.8 kg |
| Respiratory | Reduced breath sounds and dullness at the right base; otherwise clear |
| Abdomen | Liver edge 3 cm below the right costal margin and tender; tenderness over the right lower intercostal spaces; no jaundice |
| Neurological | Vibration and position sense normal in the feet; reflexes normal; gait normal |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Amebic liver abscess** (A06.4). Ultrasound: a single round 6.2 x 5.4 cm hypoechoic lesion in segment VII of the right lobe, without gas or a fluid level, with a small right pleural effusion. Entamoeba histolytica antibody positive; stool antigen and microscopy negative, which is common with a liver abscess; two blood cultures without growth after 48 hours. With fever, a tender liver, a single right-lobe abscess, positive serology and dysentery years ago in India, this is an amebic liver abscess rather than a pyogenic one. Dr. Raghunathan agrees. It is not large or in the left lobe and shows no sign of imminent rupture, so it does not need draining now. **S**
   - Metronidazole 750 mg three times a day with food for 10 days; no alcohol (he does not drink).
   - Then paromomycin 500 mg three times a day for 7 days, not at the same time as metronidazole.
   - Nurse phone check on the third day for the fever; aspiration only if fever persists after 72 hours.
   - Acetaminophen for fever and pain.
2. **Positive interferon-gamma release assay** (R76.12). IGRA positive. Chest radiograph: raised right hemidiaphragm with blunting at the right base from the abscess, and no consolidation, cavity or enlarged nodes. Three induced sputum smears and the NAAT on the first sample are negative. Active pulmonary tuberculosis is very unlikely, and his illness is explained by the abscess; he has tuberculosis infection without evidence of disease. Airborne precautions ended. Cultures will be final in six to eight weeks; latent infection is treated only after they are negative and the abscess is treated. **S**
   - Await mycobacterial cultures.
   - Discuss latent infection treatment at the six-week visit.
3. **Vitamin B12 deficiency with anemia** (D51.3). B12 168 pg/mL on a strict vegetarian diet, with hemoglobin 11.2 g/dL and MCV 99 fL; inflammation adds to the anemia. Folate 12.4 ng/mL. Ferritin 310 ng/mL is raised by inflammation. No neurologic signs. High-dose oral replacement works without injections. **S**
   - Vitamin B12 1,000 micrograms by mouth daily, long term.
   - Blood count at the end of the abscess treatment and at about eight weeks.
4. **Vitamin D deficiency** (E55.9). 25-hydroxyvitamin D 9 ng/mL: little winter sun and no fortified foods. He asked whether the tablets contain animal products; the pharmacist explained that cholecalciferol is made from lanolin in sheep's wool, that the tablet has no gelatin, and that a lichen-based form exists; he chose the standard tablet. **S**
   - Cholecalciferol 50,000 units weekly for 8 weeks, then 2,000 units daily.
5. **Adjustment disorder with depressed mood** (F43.21). He is relieved that the illness has a name and a treatment, and still low and lonely. Safety reviewed: no thoughts of suicide or self-harm; the safety plan and the 988 Suicide & Crisis Lifeline are in his phone. He agreed to see the university counseling service. **S**
   - First counseling appointment this week, at a time he chose.
   - Dietitian visit next week.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Temperature, symptoms and abdominal examination (liver tenderness, right lower rib tenderness) | Every visit | Completed today | 38.2 °C; tender liver edge 3 cm below the costal margin; right intercostal tenderness |
| Examination | Weight and BMI | Every visit | Completed today | 51.8 kg, BMI 19.0 |
| Imaging | Liver imaging | At diagnosis; repeat only for no response or a complication | Completed today | Single 6.2 x 5.4 cm right-lobe abscess; no drainage needed |
| Laboratory | Entamoeba histolytica serology, stool antigen and microscopy, blood cultures | At diagnosis | Completed today | Serology positive; stool antigen and microscopy negative; blood cultures no growth at 48 hours |
| Laboratory | Sputum acid-fast smears, NAAT and mycobacterial cultures | Three samples at baseline; cultures final at 6 to 8 weeks | Completed today | Three smears and the first NAAT negative; cultures pending |
| Laboratory | Interferon-gamma release assay and chest radiograph | At baseline | Completed today | IGRA positive; radiograph without lung disease |
| Laboratory | Blood count and C-reactive protein | At diagnosis, at the end of the tissue course, then until normal | Up to date | At intake: white cells 13.6, hemoglobin 11.2, platelets 412; CRP 92 mg/L |
| Laboratory | Liver tests (alkaline phosphatase, ALT, AST, bilirubin, albumin) | At diagnosis, at the end of therapy, and before and during rifampin | Up to date | At intake: alkaline phosphatase 214, ALT 46 U/L, albumin 3.2 g/dL |
| Medication safety | Amebicide safety and completion (nausea, metallic taste, numbness on metronidazole; diarrhea on paromomycin; no overlap) | At the start and every visit during treatment | Completed today | Side effects explained; metronidazole started today, paromomycin to follow and not overlap |
| Examination | Response to vitamin B12 replacement | Reticulocyte count at 1 week; blood count at about 8 weeks; neurologic examination at diagnosis | Completed today | Neurologic examination normal; B12 started today; reticulocyte count due in one week |
| Laboratory | 25-hydroxyvitamin D | At diagnosis; after repletion | Up to date | 9 ng/mL at intake; repletion started today |
| Self-management | Diet and weight plan within his vegetarian rules | Every visit | Completed today | Dietitian visit booked for next week |
| Survey | PHQ-9 and GAD-7 | At least monthly while symptoms are active | Up to date | PHQ-9 12 and GAD-7 9 two days ago |
| Survey | Suicide-risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan and the 988 Lifeline in his phone |
| Self-management | Support far from home (counseling, contact with family and community, department and fellowship) | Every visit | Completed today | Counseling booked; letter for his fellowship given; international student office contacted with his agreement |
| Referral | Infectious diseases review | At diagnosis; then at six weeks for the cultures and latent infection | Completed today | Seen by Dr. Raghunathan today |

## Goal progress

- A diagnosis within days, with tuberculosis either confirmed or excluded before any treatment that could hide it. In progress; target 1917-02-23. **S**
- No fever, the abscess treated, and the luminal course completed. In progress; target 1917-04-20. **S**
- Regain at least half of the lost weight within three months, on a diet that keeps his rules. In progress; target 1917-04-20. **S**
- Vitamin B12 and vitamin D in the normal range and the anemia resolved. In progress; target 1917-04-20. **S**
- PHQ-9 below 10 with no thoughts of self-harm, and regular contact with people who matter to him. In progress; target 1917-04-20. **S**
- Complete four months of rifampin for latent tuberculosis infection. In progress; target 1917-04-20. **S**

## Medication changes

- Started: Metronidazole 250 mg oral tablet, three tablets (750 mg) three times a day with food for 10 days **S**
- Started: Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet daily **S**
- Started: Cholecalciferol 50,000 unit (1.25 mg) oral tablet, one tablet once a week for 8 weeks **S**

## Guideline basis

- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016), ATS, CDC and IDSA (Clin Infect Dis 2016)
- Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017), ATS, IDSA and CDC (Clin Infect Dis 2017)
- DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026), Centers for Disease Control and Prevention
- A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis (2018), Shirley DT et al., Open Forum Infect Dis 2018
- Position of the Academy of Nutrition and Dietetics: Vegetarian Diets (2016), Academy of Nutrition and Dietetics (J Acad Nutr Diet 2016)
- CMID: Clinical Monitoring Intelligence Database, anemia and depression monographs (2026), Aether Forge
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Nurse phone call on the third day of metronidazole. Review in 12 days, at the end of metronidazole, with a blood count, CRP and liver tests. Call at once for severe abdominal pain, worse breathlessness, fainting or yellowing of the eyes. **S**
- Next scheduled visit 1917-01-26: day 12: end of metronidazole and start of paromomycin, blood count, CRP and liver tests, mood and safety review. **S**
